Adebowale Adeniran, MD
Biography
Adebowale Adeniran, MD, is a pathologist who specializes in diagnosing diseases of the genitourinary system (reproductive and urinary organs). He identifies kidney, prostate, and bladder cancers from patients’ biopsies. Dr. Adeniran also specializes in diagnosing thyroid diseases and cancer.
“The principal role of the pathologist is to provide an accurate diagnosis of a patient’s condition, which allows the physician to refine treatment options,” he says. “Pathologists and physicians work together to toward providing the best patient care.”
Dr. Adeniran decided to pursue pathology as a specialty during an academic fellowship at the University of Cincinnati Medical Center. “I saw the impact pathologists could have in terms treatment for patients by the diagnoses they made,” he says.
As director of the cytopathology and cytology labs at Yale School of Medicine, Dr. Adeniran oversees those daily operations and provides guidance to medical students and residents who are completing their training after medical school.
At the medical school, Dr. Adeniran is associate professor of pathology. In his research, he investigates the basic biology behind a cancer called papillary renal cell carcinoma and also works to better understand the molecular underpinnings of thyroid cancer.
Titles
- Professor of Pathology
- Director of Cytopathology
- Director, Cytology Laboratory
- Director, Cytopathology Fellowship Program, Pathology
- Director, Anatomic Pathology Elective Program, Pathology
Education & Training
- FellowMemorial Sloan Kettering Cancer Center (2008)
- FellowM.D. Anderson Cancer Center (2007)
- ResidentUniversity of Cincinnati Medical Center (2006)
- MDUniversity of Ibadan (1995)
Languages Spoken
- English
- Yorùbá (Yoruba)
Additional Information
- The Averill A. Liebow Award for Excellence in the Teaching of Pathology Residents: Department of Pathology, Yale School of Medicine (2022)
- Urology Residents Teacher of the year Award: Department of Urology, Yale School of Medicine (2014)
- The Averill A. Liebow Award for Excellence in the Teaching of Pathology Resident: Department of Pathology, Yale University School of Medicine (2011)
- 2007 Benjamin Castleman Award for the best published paper in the field of human pathology: United States and Canadian Academy of Pathology (USCAP) (2007)
- 2005 Resident Education Scholarship: The Group for Research in Pathology Education (GRIPE) (2005)
- AB of Pathology, Cytopathology (2008, recertified: 2019)
- AB of Pathology, Anatomic & Clinical Pathology (2007, recertified: 2018)
- International Accreditation Committee, College of American Pathologists (2022 - Present): Committee Member
- Education Committee, United States and Canadian Academy of Pathology (2021 - Present): Committee Member
- Clinical Practice Committee, American Society of Cytopathology (2020 - Present): Committee Member
- Tissue Committee, Yale New Haven Hospital (2018 - Present): Co-Chair
- CheckPath Clinical Pathology Committee, American Society for Clinical Pathology (2018 - Present): Committee Member
- Perales O, Jilaveanu L, Adeniran A, Su D, Hurwitz M, Braun D, Kluger H, Schoenfeld D. TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3. Cancer Immunology, Immunotherapy 2024, 73: 192. PMID: 39105820, PMCID: PMC11303630, DOI: 10.1007/s00262-024-03773-8.
- Mann J, Hasson N, Su D, Adeniran A, Smalley K, Djureinovic D, Jilaveanu L, Schoenfeld D, Kluger H. GP100 expression is variable in intensity in melanoma. Cancer Immunology, Immunotherapy 2024, 73: 191. PMID: 39105816, PMCID: PMC11303354, DOI: 10.1007/s00262-024-03776-5.
- Kashima S, Gupta R, Moritz V, Sadak K, Adeniran A, Humphrey P, Dinulescu D, Palmer D, Hammond S, Bosenberg M, Hurwitz M, Kenney P, Braun D. Development of anex vivo patient-derived tumor model (PDTM) to assess the tumor microenvironment in renal cell carcinoma (RCC). The Oncologist 2024, 29: s5-s6. PMCID: PMC11301923, DOI: 10.1093/oncolo/oyae181.008.
- Tripathi A, Tangen C, Plets M, Li X, Tretiakova M, Humphrey P, Adeniran A, Barata P, Gulati S, Bergerot C, Pruthi D, Thompson I, Lara P, Lerner S, Pal S, Shuch B. Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinoma. BJU International 2024 PMID: 39014969, DOI: 10.1111/bju.16403.
- Takeda K, Adeniran A, Levi A, Tang H, Cai G. Cytomorphological characteristics of low‐grade papillary urothelial carcinoma in voided urine samples: Distinction from benign and high‐grade papillary urothelial carcinoma. Cytopathology 2024 PMID: 38992916, DOI: 10.1111/cyt.13413.
- Takeda K, Cai G, Adeniran A, Sun T. Reevaluation of ovarian cyst fine-needle aspiration cytology: A 10-year institutional experience. American Journal Of Clinical Pathology 2024, aqae077. PMID: 38916141, DOI: 10.1093/ajcp/aqae077.
- Adeniran A, Shuch B, Humphrey P. Sarcomatoid and Rhabdoid Renal Cell Carcinoma. The American Journal Of Surgical Pathology 2024, 48: e65-e88. PMID: 38736105, DOI: 10.1097/pas.0000000000002233.
- Khajir G, Sun T, Wang H, Sprenkle P, Adeniran A, Cai G, Levi A. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow‐up. Cytopathology 2023, 35: 235-241. PMID: 37916579, DOI: 10.1111/cyt.13328.
- Kashima S, Soulati H, Madsen K, Sadak K, Wirth L, Hurwitz M, Kluger H, Sznol M, Humphrey P, Adeniran A, Kenney P, Braun D. 542 TIGIT as a potential therapeutic target in renal cell carcinoma. 2023, a616-a616. DOI: 10.1136/jitc-2023-sitc2023.0542.
- Schoenfeld D, Moutafi M, Martinez S, Djureinovic D, Merkin R, Adeniran A, Braun D, Signoretti S, Choueiri T, Parisi F, Hurwitz M, Rimm D, Wei W, Jilaveanu L, Kluger H. Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases. Journal For ImmunoTherapy Of Cancer 2023, 11: e007240. PMID: 37586773, PMCID: PMC10432651, DOI: 10.1136/jitc-2023-007240.
- Sardana R, Abi‐Raad R, Adeniran A, Cai G. Utility of parathyroid hormone immunocytochemistry in fine needle aspiration diagnosis of parathyroid tissue. Cytopathology 2023, 34: 597-602. PMID: 37534757, DOI: 10.1111/cyt.13283.
- Tripathi A, Tangen C, Li X, Tretiakova M, Humphrey P, Adeniran A, Barata P, Gulati S, Bergerot C, Pruthi D, Thompson I, Lara P, Pal S, Shuch B. Pathologic concordance rate and outcomes by histologic subtype in advanced papillary renal cell (pRCC) carcinoma: An analysis from the SWOG S1500 (PAPMET) trial. Journal Of Clinical Oncology 2023, 41: 4562-4562. DOI: 10.1200/jco.2023.41.16_suppl.4562.
- Caulfield J, Aizenbud L, Perdigoto A, Meffre E, Jilaveanu L, Michalek D, Rich S, Aizenbud Y, Adeniran A, Herold K, Austin M, Kluger H. Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors. Journal For ImmunoTherapy Of Cancer 2023, 11: e006570. PMID: 36898736, PMCID: PMC10008335, DOI: 10.1136/jitc-2022-006570.
- Meiklejohn K, Hrones M, Wang M, Prasad M, Cai G, Adeniran A, Gilani S. Diagnosis of acinic cell carcinoma of the salivary gland on cytology specimens: Role of NOR‐1 (NR4A3) immunohistochemistry. Cytopathology 2023, 34: 219-224. PMID: 36825365, DOI: 10.1111/cyt.13222.
- Schoenfeld D, Merkin R, Moutafi M, Martinez S, Adeniran A, Kumar D, Jilaveanu L, Hurwitz M, Rimm D, Kluger H. Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance. Frontiers In Oncology 2022, 12: 990367. PMID: 36313654, PMCID: PMC9608089, DOI: 10.3389/fonc.2022.990367.
- Murry J, Eno C, Mendhiratta N, Ye H, Sisk A, Adeniran A, Shuch B, Kang S. 40. Correlation of histology, CCND1 over-expression, and CCND1 rearrangement in Renal Cell Carcinomas. Cancer Genetics 2021, 252: s14. DOI: 10.1016/j.cancergen.2021.01.051.
- Pal S, Tangen C, Thompson I, Haas N, George D, Heng D, Shuch B, Stein M, Tretiakova M, Humphrey P, Adeniran A, Narayan V, Bjarnason G, Vaishampayan U, Alva A, Zhang T, Cole S, Plets M, Wright J, Lara P. Sunitinib versus cabozantinib, crizotinib or savolitinib in metastatic papillary renal cell carcinoma (pRCC): Results from the randomized phase II SWOG 1500 study. Journal Of Clinical Oncology 2021, 39: 270-270. DOI: 10.1200/jco.2021.39.6_suppl.270.
- Oria V, Zhang H, Zhu H, Deng G, Zito C, Rane C, Zhang S, Weiss S, Tran T, Adeniran A, Zhang F, Zhou J, Kluger Y, Bosenberg M, Kluger H, Jilaveanu L. 19. PLEKHA5 REGULATES TUMOR GROWTH IN METASTATIC MELANOMA. Neuro-Oncology Advances 2020, 2: ii3-ii3. PMCID: PMC7401364, DOI: 10.1093/noajnl/vdaa073.009.
- Cai G, Adeniran A. Overview. 2019, 3-11. DOI: 10.1007/978-3-030-21799-0_1.
- Adeniran A. Salivary Gland. 2019, 93-118. DOI: 10.1007/978-3-030-21799-0_5.
- Adeniran A. Telecytopathology. 2019, 413-420. DOI: 10.1007/978-3-030-21799-0_16.
- Adeniran A. Kidney and Adrenal Gland. 2019, 187-223. DOI: 10.1007/978-3-030-21799-0_8.
- Adeniran A. Thyroid. 2019, 31-60. DOI: 10.1007/978-3-030-21799-0_3.
- van Riet PA, Cahen DL, Biermann K, Hansen B, Larghi A, Rindi G, Fellegara G, Arcidiacono P, Doglioni C, Decarli N, Iglesias‐Garcia J, Abdulkader I, Iglesias H, Kitano M, Chikugo T, Yasukawa S, van der Valk H, Nguyen N, Ruszkiewicz A, Giovannini M, Poizat F, van der Merwe S, Roskams T, Santo E, Marmor S, Chang K, Lin F, Farrell J, Robert M, Bucobo J, Heimann A, Baldaque‐Silva F, Moro C, Bruno M, Attili F, Aslanian H, Adeniran A, Lee J, Petrone M, Bories E, Scapa E, Buscaglia J, Wu M. Agreement on endoscopic ultrasonography‐guided tissue specimens: Comparing a 20‐G fine‐needle biopsy to a 25‐G fine‐needle aspiration needle among academic and non‐academic pathologists. Digestive Endoscopy 2019, 31: 690-697. PMID: 31290176, PMCID: PMC6900144, DOI: 10.1111/den.13424.
- van Riet P, Larghi A, Attili F, Rindi G, Nguyen N, Ruszkiewicz A, Kitano M, Chikugo T, Aslanian H, Farrell J, Robert M, Adeniran A, Van Der Merwe S, Roskams T, Chang K, Lin F, Lee J, Arcidiacono P, Petrone M, Doglioni C, Iglesias-Garcia J, Nallib I, Giovannini M, Bories E, Poizat F, Santo E, Scapa E, Marmor S, Bucobo J, Buscaglia J, Heimann A, Wu M, Silva F, Moro C, Erler N, Biermann K, Poley J, Cahen D, Bruno M. Su1406 A MULTICENTER RANDOMIZED TRIAL COMPARING A 25G EUS FINE NEEDLE ASPIRATION DEVICE WITH A 20G EUS FINE NEEDLE BIOPSY DEVICE. Gastrointestinal Endoscopy 2018, 87: ab342-ab343. DOI: 10.1016/j.gie.2018.04.1736.
- Lu B, Gupta R, Ribeiro M, Stewart T, Chiang V, Contessa J, Adeniran A, Kluger H, Jilaveanu L, Schalper K, Goldberg S. PD-L1 expression and tumor-infiltrating lymphocytes in lung cancer brain metastases. Journal Of Clinical Oncology 2018, 36: e24116-e24116. DOI: 10.1200/jco.2018.36.15_suppl.e24116.
- van Riet P, Arcidiacono P, Petrone M, Dabizzi E, Nguyen N, Kitano M, Chang K, Van Der Merwe S, Bruno M, Cahen D, Larghi A, Iglesias-Garcia J, Giovannini M, Santo E, Silva F, Bucobo J, Robert M, Adeniran A, Celli R, Aslanian H, Farrell J. Su1353 Diagnostic Accuracy of Combined Needle Use of the New 20G Procore Fnb and the 25G Fna Needle in Solid Gi-Lesions. Gastrointestinal Endoscopy 2017, 85: ab347. DOI: 10.1016/j.gie.2017.03.799.
- van Riet P, Arcidiacono P, Petrone M, Dabizzi E, Nguyen N, Kitano M, Chang K, van der Merwe S, Bruno M, Cahen D, Larghi A, Iglesias-Garcia J, Giovannini M, Santo E, Silva F, Bucobo J, Robert M, Adeniran A, Celli R, Aslanian H, Farrell J. P-LUM-06: Diagnostic accuracy of combined needle use of the new 20-gauge procore fine needle biopsy and the 25-gauge fine needle aspiration needle in solid gastrointestinal lesions. Endoscopic Ultrasound 2017, 6: s12-s12. PMCID: PMC5569758, DOI: 10.4103/2303-9027.212309.
- Peterss S, Mansour AM, Ross JA, Vaitkeviciute I, Charilaou P, Dumfarth J, Fang H, Ziganshin BA, Rizzo JA, Adeniran AJ, Elefteriades JA. Changing Pathology of the Thoracic Aorta From Acute to Chronic Dissection Literature Review and Insights. Journal Of The American College Of Cardiology 2016, 68: 1054-1065. PMID: 27585511, DOI: 10.1016/j.jacc.2016.05.091.
- Mafolasire A, Yao X, Nawaf C, Suarez‐Sarmiento A, Chow W, Zhao W, Corley D, Hofmann JN, Purdue M, Adeniran AJ, Shuch B. Racial disparities in renal cell carcinoma: a single‐payer healthcare experience. Cancer Medicine 2016, 5: 2101-2108. PMID: 27228559, PMCID: PMC4884637, DOI: 10.1002/cam4.755.
- Bi M, Zhao S, Merino M, Said J, Adeniran A, Nawaf C, Xie Z, Boeke M, Valera V, Pantuck A, Belldegrun A, Kluger H, Lifton R, Shuch B. MP71-12 GENOMIC CHARACTERIZATION OF SARCOMATOID TRANSFORMATION IN CLEAR CELL RENAL CELL CARCINOMA. Journal Of Urology 2016, 195: e920. DOI: 10.1016/j.juro.2016.02.1458.
- Bi M, Zhao S, Said JW, Merino MJ, Adeniran AJ, Xie Z, Nawaf CB, Choi J, Belldegrun AS, Pantuck AJ, Kluger HM, Bilgüvar K, Lifton RP, Shuch B. Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma. Proceedings Of The National Academy Of Sciences Of The United States Of America 2016, 113: 2170-2175. PMID: 26864202, PMCID: PMC4776463, DOI: 10.1073/pnas.1525735113.
- Bi X, Zhao S, Adeniran A, Kluger H, Xie Z, Nawaf C, Merino M, Valera V, Pantuck A, Said J, Belldegrun A, Lifton R, Shuch B. Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma. Journal Of Clinical Oncology 2016, 34: 509-509. DOI: 10.1200/jco.2016.34.2_suppl.509.
- Nawaf C, Rosoff J, Adeniran A, Humphrey P, Shuch B. The incidence of adverse pathologic characteristics in small renal masses as size increases. Journal Of Clinical Oncology 2016, 34: 596-596. DOI: 10.1200/jco.2016.34.2_suppl.596.
- Adeniran A, Chhieng D. Common Diagnostic Pitfalls in Thyroid Cytopathology. 2016 DOI: 10.1007/978-3-319-31602-4.
- Hurwitz M, Adeniran A, Yao X, Hafez N, Schalper K, Rimm D, Petrylak D. The effect of BCG intravesical therapy and recurrence on PDL1 expression in non-invasive bladder cancers. Journal Of Clinical Oncology 2015, 33: e15504-e15504. DOI: 10.1200/jco.2015.33.15_suppl.e15504.
- Adeniran A. Thyroid and Parathyroid Tumors. 2015, 341-374. DOI: 10.1007/978-3-319-16304-8_11.
- Shen S, Adeniran A, Tamboli P. 13 Nonepithelial Neoplasms of the Kidney. 2013, 269-290. DOI: 10.1016/b978-0-443-06966-6.00015-5.
- Feifer A, Savage C, Rayala H, Lowrance W, Gotto G, Sprenkle P, Gupta A, Taylor J, Bernstein M, Adeniran A, Tickoo SK, Reuter VE, Russo P. Prognostic Impact of Muscular Venous Branch Invasion in Localized Renal Cell Carcinoma Cases. Journal Of Urology 2010, 185: 37-42. PMID: 21074196, PMCID: PMC3437930, DOI: 10.1016/j.juro.2010.08.084.
Biography
Adebowale Adeniran, MD, is a pathologist who specializes in diagnosing diseases of the genitourinary system (reproductive and urinary organs). He identifies kidney, prostate, and bladder cancers from patients’ biopsies. Dr. Adeniran also specializes in diagnosing thyroid diseases and cancer.
“The principal role of the pathologist is to provide an accurate diagnosis of a patient’s condition, which allows the physician to refine treatment options,” he says. “Pathologists and physicians work together to toward providing the best patient care.”
Dr. Adeniran decided to pursue pathology as a specialty during an academic fellowship at the University of Cincinnati Medical Center. “I saw the impact pathologists could have in terms treatment for patients by the diagnoses they made,” he says.
As director of the cytopathology and cytology labs at Yale School of Medicine, Dr. Adeniran oversees those daily operations and provides guidance to medical students and residents who are completing their training after medical school.
At the medical school, Dr. Adeniran is associate professor of pathology. In his research, he investigates the basic biology behind a cancer called papillary renal cell carcinoma and also works to better understand the molecular underpinnings of thyroid cancer.
Titles
- Professor of Pathology
- Director of Cytopathology
- Director, Cytology Laboratory
- Director, Cytopathology Fellowship Program, Pathology
- Director, Anatomic Pathology Elective Program, Pathology
Education & Training
- FellowMemorial Sloan Kettering Cancer Center (2008)
- FellowM.D. Anderson Cancer Center (2007)
- ResidentUniversity of Cincinnati Medical Center (2006)
- MDUniversity of Ibadan (1995)
Languages Spoken
- English
- Yorùbá (Yoruba)
Additional Information
- The Averill A. Liebow Award for Excellence in the Teaching of Pathology Residents: Department of Pathology, Yale School of Medicine (2022)
- Urology Residents Teacher of the year Award: Department of Urology, Yale School of Medicine (2014)
- The Averill A. Liebow Award for Excellence in the Teaching of Pathology Resident: Department of Pathology, Yale University School of Medicine (2011)
- 2007 Benjamin Castleman Award for the best published paper in the field of human pathology: United States and Canadian Academy of Pathology (USCAP) (2007)
- 2005 Resident Education Scholarship: The Group for Research in Pathology Education (GRIPE) (2005)
- AB of Pathology, Cytopathology (2008, recertified: 2019)
- AB of Pathology, Anatomic & Clinical Pathology (2007, recertified: 2018)
- International Accreditation Committee, College of American Pathologists (2022 - Present): Committee Member
- Education Committee, United States and Canadian Academy of Pathology (2021 - Present): Committee Member
- Clinical Practice Committee, American Society of Cytopathology (2020 - Present): Committee Member
- Tissue Committee, Yale New Haven Hospital (2018 - Present): Co-Chair
- CheckPath Clinical Pathology Committee, American Society for Clinical Pathology (2018 - Present): Committee Member
- Perales O, Jilaveanu L, Adeniran A, Su D, Hurwitz M, Braun D, Kluger H, Schoenfeld D. TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3. Cancer Immunology, Immunotherapy 2024, 73: 192. PMID: 39105820, PMCID: PMC11303630, DOI: 10.1007/s00262-024-03773-8.
- Mann J, Hasson N, Su D, Adeniran A, Smalley K, Djureinovic D, Jilaveanu L, Schoenfeld D, Kluger H. GP100 expression is variable in intensity in melanoma. Cancer Immunology, Immunotherapy 2024, 73: 191. PMID: 39105816, PMCID: PMC11303354, DOI: 10.1007/s00262-024-03776-5.
- Kashima S, Gupta R, Moritz V, Sadak K, Adeniran A, Humphrey P, Dinulescu D, Palmer D, Hammond S, Bosenberg M, Hurwitz M, Kenney P, Braun D. Development of anex vivo patient-derived tumor model (PDTM) to assess the tumor microenvironment in renal cell carcinoma (RCC). The Oncologist 2024, 29: s5-s6. PMCID: PMC11301923, DOI: 10.1093/oncolo/oyae181.008.
- Tripathi A, Tangen C, Plets M, Li X, Tretiakova M, Humphrey P, Adeniran A, Barata P, Gulati S, Bergerot C, Pruthi D, Thompson I, Lara P, Lerner S, Pal S, Shuch B. Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinoma. BJU International 2024 PMID: 39014969, DOI: 10.1111/bju.16403.
- Takeda K, Adeniran A, Levi A, Tang H, Cai G. Cytomorphological characteristics of low‐grade papillary urothelial carcinoma in voided urine samples: Distinction from benign and high‐grade papillary urothelial carcinoma. Cytopathology 2024 PMID: 38992916, DOI: 10.1111/cyt.13413.
- Takeda K, Cai G, Adeniran A, Sun T. Reevaluation of ovarian cyst fine-needle aspiration cytology: A 10-year institutional experience. American Journal Of Clinical Pathology 2024, aqae077. PMID: 38916141, DOI: 10.1093/ajcp/aqae077.
- Adeniran A, Shuch B, Humphrey P. Sarcomatoid and Rhabdoid Renal Cell Carcinoma. The American Journal Of Surgical Pathology 2024, 48: e65-e88. PMID: 38736105, DOI: 10.1097/pas.0000000000002233.
- Khajir G, Sun T, Wang H, Sprenkle P, Adeniran A, Cai G, Levi A. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow‐up. Cytopathology 2023, 35: 235-241. PMID: 37916579, DOI: 10.1111/cyt.13328.
- Kashima S, Soulati H, Madsen K, Sadak K, Wirth L, Hurwitz M, Kluger H, Sznol M, Humphrey P, Adeniran A, Kenney P, Braun D. 542 TIGIT as a potential therapeutic target in renal cell carcinoma. 2023, a616-a616. DOI: 10.1136/jitc-2023-sitc2023.0542.
- Schoenfeld D, Moutafi M, Martinez S, Djureinovic D, Merkin R, Adeniran A, Braun D, Signoretti S, Choueiri T, Parisi F, Hurwitz M, Rimm D, Wei W, Jilaveanu L, Kluger H. Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases. Journal For ImmunoTherapy Of Cancer 2023, 11: e007240. PMID: 37586773, PMCID: PMC10432651, DOI: 10.1136/jitc-2023-007240.
- Sardana R, Abi‐Raad R, Adeniran A, Cai G. Utility of parathyroid hormone immunocytochemistry in fine needle aspiration diagnosis of parathyroid tissue. Cytopathology 2023, 34: 597-602. PMID: 37534757, DOI: 10.1111/cyt.13283.
- Tripathi A, Tangen C, Li X, Tretiakova M, Humphrey P, Adeniran A, Barata P, Gulati S, Bergerot C, Pruthi D, Thompson I, Lara P, Pal S, Shuch B. Pathologic concordance rate and outcomes by histologic subtype in advanced papillary renal cell (pRCC) carcinoma: An analysis from the SWOG S1500 (PAPMET) trial. Journal Of Clinical Oncology 2023, 41: 4562-4562. DOI: 10.1200/jco.2023.41.16_suppl.4562.
- Caulfield J, Aizenbud L, Perdigoto A, Meffre E, Jilaveanu L, Michalek D, Rich S, Aizenbud Y, Adeniran A, Herold K, Austin M, Kluger H. Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors. Journal For ImmunoTherapy Of Cancer 2023, 11: e006570. PMID: 36898736, PMCID: PMC10008335, DOI: 10.1136/jitc-2022-006570.
- Meiklejohn K, Hrones M, Wang M, Prasad M, Cai G, Adeniran A, Gilani S. Diagnosis of acinic cell carcinoma of the salivary gland on cytology specimens: Role of NOR‐1 (NR4A3) immunohistochemistry. Cytopathology 2023, 34: 219-224. PMID: 36825365, DOI: 10.1111/cyt.13222.
- Schoenfeld D, Merkin R, Moutafi M, Martinez S, Adeniran A, Kumar D, Jilaveanu L, Hurwitz M, Rimm D, Kluger H. Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance. Frontiers In Oncology 2022, 12: 990367. PMID: 36313654, PMCID: PMC9608089, DOI: 10.3389/fonc.2022.990367.
- Murry J, Eno C, Mendhiratta N, Ye H, Sisk A, Adeniran A, Shuch B, Kang S. 40. Correlation of histology, CCND1 over-expression, and CCND1 rearrangement in Renal Cell Carcinomas. Cancer Genetics 2021, 252: s14. DOI: 10.1016/j.cancergen.2021.01.051.
- Pal S, Tangen C, Thompson I, Haas N, George D, Heng D, Shuch B, Stein M, Tretiakova M, Humphrey P, Adeniran A, Narayan V, Bjarnason G, Vaishampayan U, Alva A, Zhang T, Cole S, Plets M, Wright J, Lara P. Sunitinib versus cabozantinib, crizotinib or savolitinib in metastatic papillary renal cell carcinoma (pRCC): Results from the randomized phase II SWOG 1500 study. Journal Of Clinical Oncology 2021, 39: 270-270. DOI: 10.1200/jco.2021.39.6_suppl.270.
- Oria V, Zhang H, Zhu H, Deng G, Zito C, Rane C, Zhang S, Weiss S, Tran T, Adeniran A, Zhang F, Zhou J, Kluger Y, Bosenberg M, Kluger H, Jilaveanu L. 19. PLEKHA5 REGULATES TUMOR GROWTH IN METASTATIC MELANOMA. Neuro-Oncology Advances 2020, 2: ii3-ii3. PMCID: PMC7401364, DOI: 10.1093/noajnl/vdaa073.009.
- Cai G, Adeniran A. Overview. 2019, 3-11. DOI: 10.1007/978-3-030-21799-0_1.
- Adeniran A. Salivary Gland. 2019, 93-118. DOI: 10.1007/978-3-030-21799-0_5.
- Adeniran A. Telecytopathology. 2019, 413-420. DOI: 10.1007/978-3-030-21799-0_16.
- Adeniran A. Kidney and Adrenal Gland. 2019, 187-223. DOI: 10.1007/978-3-030-21799-0_8.
- Adeniran A. Thyroid. 2019, 31-60. DOI: 10.1007/978-3-030-21799-0_3.
- van Riet PA, Cahen DL, Biermann K, Hansen B, Larghi A, Rindi G, Fellegara G, Arcidiacono P, Doglioni C, Decarli N, Iglesias‐Garcia J, Abdulkader I, Iglesias H, Kitano M, Chikugo T, Yasukawa S, van der Valk H, Nguyen N, Ruszkiewicz A, Giovannini M, Poizat F, van der Merwe S, Roskams T, Santo E, Marmor S, Chang K, Lin F, Farrell J, Robert M, Bucobo J, Heimann A, Baldaque‐Silva F, Moro C, Bruno M, Attili F, Aslanian H, Adeniran A, Lee J, Petrone M, Bories E, Scapa E, Buscaglia J, Wu M. Agreement on endoscopic ultrasonography‐guided tissue specimens: Comparing a 20‐G fine‐needle biopsy to a 25‐G fine‐needle aspiration needle among academic and non‐academic pathologists. Digestive Endoscopy 2019, 31: 690-697. PMID: 31290176, PMCID: PMC6900144, DOI: 10.1111/den.13424.
- van Riet P, Larghi A, Attili F, Rindi G, Nguyen N, Ruszkiewicz A, Kitano M, Chikugo T, Aslanian H, Farrell J, Robert M, Adeniran A, Van Der Merwe S, Roskams T, Chang K, Lin F, Lee J, Arcidiacono P, Petrone M, Doglioni C, Iglesias-Garcia J, Nallib I, Giovannini M, Bories E, Poizat F, Santo E, Scapa E, Marmor S, Bucobo J, Buscaglia J, Heimann A, Wu M, Silva F, Moro C, Erler N, Biermann K, Poley J, Cahen D, Bruno M. Su1406 A MULTICENTER RANDOMIZED TRIAL COMPARING A 25G EUS FINE NEEDLE ASPIRATION DEVICE WITH A 20G EUS FINE NEEDLE BIOPSY DEVICE. Gastrointestinal Endoscopy 2018, 87: ab342-ab343. DOI: 10.1016/j.gie.2018.04.1736.
- Lu B, Gupta R, Ribeiro M, Stewart T, Chiang V, Contessa J, Adeniran A, Kluger H, Jilaveanu L, Schalper K, Goldberg S. PD-L1 expression and tumor-infiltrating lymphocytes in lung cancer brain metastases. Journal Of Clinical Oncology 2018, 36: e24116-e24116. DOI: 10.1200/jco.2018.36.15_suppl.e24116.
- van Riet P, Arcidiacono P, Petrone M, Dabizzi E, Nguyen N, Kitano M, Chang K, Van Der Merwe S, Bruno M, Cahen D, Larghi A, Iglesias-Garcia J, Giovannini M, Santo E, Silva F, Bucobo J, Robert M, Adeniran A, Celli R, Aslanian H, Farrell J. Su1353 Diagnostic Accuracy of Combined Needle Use of the New 20G Procore Fnb and the 25G Fna Needle in Solid Gi-Lesions. Gastrointestinal Endoscopy 2017, 85: ab347. DOI: 10.1016/j.gie.2017.03.799.
- van Riet P, Arcidiacono P, Petrone M, Dabizzi E, Nguyen N, Kitano M, Chang K, van der Merwe S, Bruno M, Cahen D, Larghi A, Iglesias-Garcia J, Giovannini M, Santo E, Silva F, Bucobo J, Robert M, Adeniran A, Celli R, Aslanian H, Farrell J. P-LUM-06: Diagnostic accuracy of combined needle use of the new 20-gauge procore fine needle biopsy and the 25-gauge fine needle aspiration needle in solid gastrointestinal lesions. Endoscopic Ultrasound 2017, 6: s12-s12. PMCID: PMC5569758, DOI: 10.4103/2303-9027.212309.
- Peterss S, Mansour AM, Ross JA, Vaitkeviciute I, Charilaou P, Dumfarth J, Fang H, Ziganshin BA, Rizzo JA, Adeniran AJ, Elefteriades JA. Changing Pathology of the Thoracic Aorta From Acute to Chronic Dissection Literature Review and Insights. Journal Of The American College Of Cardiology 2016, 68: 1054-1065. PMID: 27585511, DOI: 10.1016/j.jacc.2016.05.091.
- Mafolasire A, Yao X, Nawaf C, Suarez‐Sarmiento A, Chow W, Zhao W, Corley D, Hofmann JN, Purdue M, Adeniran AJ, Shuch B. Racial disparities in renal cell carcinoma: a single‐payer healthcare experience. Cancer Medicine 2016, 5: 2101-2108. PMID: 27228559, PMCID: PMC4884637, DOI: 10.1002/cam4.755.
- Bi M, Zhao S, Merino M, Said J, Adeniran A, Nawaf C, Xie Z, Boeke M, Valera V, Pantuck A, Belldegrun A, Kluger H, Lifton R, Shuch B. MP71-12 GENOMIC CHARACTERIZATION OF SARCOMATOID TRANSFORMATION IN CLEAR CELL RENAL CELL CARCINOMA. Journal Of Urology 2016, 195: e920. DOI: 10.1016/j.juro.2016.02.1458.
- Bi M, Zhao S, Said JW, Merino MJ, Adeniran AJ, Xie Z, Nawaf CB, Choi J, Belldegrun AS, Pantuck AJ, Kluger HM, Bilgüvar K, Lifton RP, Shuch B. Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma. Proceedings Of The National Academy Of Sciences Of The United States Of America 2016, 113: 2170-2175. PMID: 26864202, PMCID: PMC4776463, DOI: 10.1073/pnas.1525735113.
- Bi X, Zhao S, Adeniran A, Kluger H, Xie Z, Nawaf C, Merino M, Valera V, Pantuck A, Said J, Belldegrun A, Lifton R, Shuch B. Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma. Journal Of Clinical Oncology 2016, 34: 509-509. DOI: 10.1200/jco.2016.34.2_suppl.509.
- Nawaf C, Rosoff J, Adeniran A, Humphrey P, Shuch B. The incidence of adverse pathologic characteristics in small renal masses as size increases. Journal Of Clinical Oncology 2016, 34: 596-596. DOI: 10.1200/jco.2016.34.2_suppl.596.
- Adeniran A, Chhieng D. Common Diagnostic Pitfalls in Thyroid Cytopathology. 2016 DOI: 10.1007/978-3-319-31602-4.
- Hurwitz M, Adeniran A, Yao X, Hafez N, Schalper K, Rimm D, Petrylak D. The effect of BCG intravesical therapy and recurrence on PDL1 expression in non-invasive bladder cancers. Journal Of Clinical Oncology 2015, 33: e15504-e15504. DOI: 10.1200/jco.2015.33.15_suppl.e15504.
- Adeniran A. Thyroid and Parathyroid Tumors. 2015, 341-374. DOI: 10.1007/978-3-319-16304-8_11.
- Shen S, Adeniran A, Tamboli P. 13 Nonepithelial Neoplasms of the Kidney. 2013, 269-290. DOI: 10.1016/b978-0-443-06966-6.00015-5.
- Feifer A, Savage C, Rayala H, Lowrance W, Gotto G, Sprenkle P, Gupta A, Taylor J, Bernstein M, Adeniran A, Tickoo SK, Reuter VE, Russo P. Prognostic Impact of Muscular Venous Branch Invasion in Localized Renal Cell Carcinoma Cases. Journal Of Urology 2010, 185: 37-42. PMID: 21074196, PMCID: PMC3437930, DOI: 10.1016/j.juro.2010.08.084.